Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:28 Apr 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1395.20 [ -1.01% ]TCS 2273.15 [ -1.28% ]

Sensex29918.40
-111.34 -0.37%

Nifty9304.05
-38.10 -0.41%

Midcap14798.45
26.00 0.18%

Smallcap15372.51
93.02 0.61%



Glenmark Pharmaceuticals Ltd :

 894.95   10.90(1.23%)

ISIN: INE935A01035  | BSE : GLENMARK  |  Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln  | Add To Watchlist

Price Information
• Open 891.00
• High 896.25
• Low 883.10
• Previous Close 884.05
• Shares Traded 68868700
• 52 Wk High Price 994.00
• 52 Wk High Date 01-11-2016
• 52 Wk Low Price 730.00
• 52 Wk Low Date 24-06-2016
• Face Value 1.00


Fundamentals
• Market Capital (Rs.cr) 24931.80
• EPS (Rs.)(TTM) 80.83
• P/E Ratio(TTM) 10.92
• Book Value (Rs.) 258.20
• Price to Book Value 3.42
• Equity (Rs.cr.) 28.22
• Traded Value (Rs.lac) 156.48


Corporate Actions
Ex-Date Purpose (Rs.)
2011-07-28 40% Dividend (0.4)
2012-07-19 200% Dividend (2)
2013-07-18 200% Dividend (2)
2014-07-10 200% Dividend (2)
2016-08-03 200% Dividend (2)


Index Names
BSE-500
BSE HC
BSE-100
BSE-200
CNX Nifty Jr.




Key Financials Latest Qrtr. Trailing Yr. Full Yr.
• Year End Dec, 2016 Dec, 2016 Mar, 2016
• Sales (Rs.cr) 2114.95 7842.04 6273.24
• Net Profit (Rs.cr) 711.31 2281.07 1469.05
• Net Profit Var (%) 170.00 28.00 29.00
• EPS (Rs) - 80.83 51.60
• P/E Ratio - 10.92 17.10
• Operating Profit Margin - 34.85 -
• CPS (Rs.) - - 55.60
• P/C Ratio - - 15.90
• Div% - - 200.00

Announcements
01-06-2016 Glenmark Pharmaceuticals Limited - FCCBs
09-05-2016 Glenmark Pharmaceuticals Limited - Updates
06-05-2015 Glenmark Pharmaceuticals Limited - Addendum
13-01-2016 Glenmark Pharmaceuticals Limited - Updates
21-02-2017 Glenmark Pharmaceuticals Limited - Updates
05-06-2015 Glenmark Pharmaceuticals Limited - Extraordinary General Meeting Updates
23-08-2012 Glenmark Pharmaceuticals - Press Release
24-10-2016 Glenmark Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Update
11-01-2017 Glenmark Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
12-02-2016 Glenmark Pharmaceuticals Limited - Extraordinary General Meeting Updates
24-12-2015 Glenmark Pharmaceuticals Limited - Postal Ballot Updates
10-04-2015 Glenmark Pharmaceuticals Limited - Press Release
03-02-2017 Glenmark Pharmaceuticals Limited - Appointment of Company Secretary/Compliance Officer
21-04-2016 Glenmark Pharmaceuticals Limited - Clarification
23-10-2015 Glenmark Pharmaceuticals Limited - Press Release
30-10-2016 Glenmark Pharmaceuticals Limited - Resignation of CompanySecretary/Compliance Officer
05-11-2014 Glenmark Pharmaceuticals Limited - 4 Press Release
29-05-2015 Glenmark Pharmaceuticals Limited - Press Release
12-10-2015 Glenmark Pharmaceuticals Limited - Annual General Meeting Updates
13-10-2014 Glenmark Pharmaceuticals Limited - ESOPs/ESOS/ESPS
05-01-2016 Glenmark Pharmaceuticals Limited - News Clarification
21-12-2015 Glenmark Pharmaceuticals Limited - Press Release
27-11-2014 Glenmark Pharmaceuticals Limited - Resignation of Director
16-12-2015 Glenmark Pharmaceuticals Limited - ESOPs/ESOS/ESPS
20-04-2015 Glenmark Pharmaceuticals Limited - Outcome of Board Meeting
02-03-2017 Glenmark Pharmaceuticals Limited - Press Release
16-10-2015 Glenmark Pharmaceuticals Limited - Trading Window
20-05-2015 Glenmark Pharmaceuticals Limited - Allotment of Securities
19-09-2014 Glenmark Pharmaceuticals Limited - Disclosure under Insider Trading Regulation
30-10-2015 Glenmark Pharmaceuticals Limited - Outcome of Board Meeting
01-06-2015 Glenmark Pharmaceuticals Limited - Resignation of Director
17-12-2014 Glenmark Pharmaceuticals Limited - Court Convened Meeting Updates
23-03-2015 Glenmark Pharmaceuticals Limited - News Clarification
26-02-2015 Glenmark Pharmaceuticals Limited - Press Release
15-07-2014 Glenmark Pharmaceuticals Limited - Press Release
04-07-2012 Glenmark Pharmaceuticals Limited - AGM / Book Closure
11-11-2011 Glenmark Pharmaceuticals Limited - Outcome of meeting
13-07-2011 Glenmark Pharmaceuticals Limited - Press Release
31-08-2012 Glenmark Pharmaceuticals Limited - Proceedings of Annual General Meeting
23-10-2014 Glenmark Pharmaceuticals Limited - Postal Ballot Updates
25-02-2015 Glenmark Pharmaceuticals Limited - Press Release
25-08-2014 Glenmark Pharmaceuticals Limited - Annual General Meeting Updates
31-10-2014 Glenmark Pharmaceuticals Limited - Outcome of Board Meeting
26-03-2013 Glenmark Pharmaceuticals Limited - Allotment of Securities
31-01-2012 Glenmark Pharmaceuticals Limited - Appointment
12-09-2014 Glenmark Pharmaceuticals Limited - Disclosure under Insider Trading Regulation
09-07-2013 Glenmark Pharmaceuticals Limited - Disclosure under Insider Trading Regulation
18-04-2013 Glenmark Pharmaceuticals Limited - ESOPs/ESOS/ESPS
25-07-2014 Glenmark Pharmaceuticals Limited - Outcome of Board Meeting
08-11-2010 Glenmark Pharmaceuticals Limited - Press Release
02-09-2011 Glenmark Pharmaceuticals Limited - Proceedings of Annual General Meeting
20-07-2015 Glenmark Pharmaceuticals Limited - Trading Window
13-01-2012 Glenmark Pharmaceuticals Limited - Updates
27-01-2016 Glenmark Pharmaceuticals Limited - Regulation 44(3) of SEBI (LODR), Reg., 2015
13-04-2016 Glenmark Pharmaceuticals Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011
31-08-2015 Glenmark Pharmaceuticals Limited - AGM/Book Closure
08-07-2013 Glenmark Pharmaceuticals Limited - AGM/Book Closure
19-11-2010 Glenmark Pharmaceuticals Limited - Allotment of Securities
18-02-2013 Glenmark Pharmaceuticals Limited - GlESOPs/ESOS/ESPS
14-11-2011 Glenmark Pharmaceuticals Limited - Outcome of Board Meeting
09-01-2013 Glenmark Pharmaceuticals Limited - Updates
08-11-2011 Glenmark Pharmaceuticals Limited - Updates
28-05-2014 Glenmark Pharmaceuticals Limited - Disclosure under Insider Trading Regulation
21-11-2014 Glenmark Pharmaceuticals Limited - Disclosure of Voting Pattern - Clause 35A
20-07-2016 Glenmark Pharmaceuticals Limited - Date of payment of dividend
11-04-2017 Glenmark Pharmaceuticals Limited - Disc. under Reg.30 of SEBI (SAST) Reg.2011
06-02-2017 Glenmark Pharmaceuticals Limited - Reply to Clarification Sought
23-09-2015 Glenmark Pharmaceuticals Limited - Disclosure of Voting Pattern - Clause 35A
26-07-2011 Glenmark Pharmaceuticals Limited - Updates
14-01-2015 Glenmark Pharmaceuticals Limited - Updates
31-12-2014 Glenmark Pharmaceuticals Limited - Disclosure of Voting Pattern - Clause 35A
31-01-2014 Glenmark Pharmaceuticals Limited - Amalgamation/Merger
07-08-2012 Glenmark Pharmaceuticals Limited - Demise
28-07-2014 Glenmark Pharmaceuticals Limited - Disclosure of Voting Pattern - Clause 35A
08-05-2013 Glenmark Pharmaceuticals Limited - Dividend
11-08-2011 Glenmark Pharmaceuticals Limited - Outcome of Annual General Meeting
08-08-2012 Glenmark Pharmaceuticals Limited - Outcome of Annual General Meeting

Gross Deliverables
Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover
28-04-2017 2871 12592 22.80 2563086 11209.00
27-04-2017 5566 17562 31.69 4917283 15648.30
26-04-2017 8298 24332 34.10 7410529 21731.20
25-04-2017 8883 27937 31.80 7994700 24964.10
24-04-2017 8456 29227 28.93 7467494 25909.90


Bulk Deals
Deal Date Client Name Type Qty Price
31-08-2015 DB INTERNATIONAL ASIA LIMITED S 2229553 1154.52
31-08-2015 DB INTERNATIONAL ASIA LIMITED B 139708 1158.66
31-08-2015 ISHARES INDIA INDEX MAURITIUS COMPANY B 1701101 1159.50



Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action




Market on Mobile



Hot Searches  •  everest industries  •  zinc  •  mahindra  •  tvs motor company  •  tvs motor
Site Map  •  Companies  •  Learning Centre  •  Insurance  •  About  •  Contact us  •  Disclaimer
© appuonline.com

Content Provided by CMOTS InfoTech